Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?


EDİGER D. , Yilmaz D., COŞKUN N. F. , Gozu O.

ASTIM ALLERJI IMMUNOLOJI, vol.8, no.3, pp.150-156, 2010 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 3
  • Publication Date: 2010
  • Title of Journal : ASTIM ALLERJI IMMUNOLOJI
  • Page Numbers: pp.150-156
  • Keywords: Asthma, allergic rhinitis, immunotherapy, adverse effects

Abstract

Objective: Allergen immunotherapy has been proven to be effective and potentially curative therapy in allergic respiratory diseases and in venom allergy. But occurance of adverse systemic reactions due to specific allergen immunotherapy (SIT) remains still major problem. In this study we aimed to assess the adverse reactions of SIT which has been given to patients diagnosed as allergic asthma and/or rhinitis.